Regardless of various arguments in the literature, earlier meta-analyses revealed that the IL-6 levels are raised in both cerebrospinal fluid (CSF) and mild cognitive impairment (MCI) plasma and in patients with AD in comparison to control persons [7]. This evidence concerns the gene IL6 and Alzheimer disease.